FormaPath demonstrate ‘mini’ nToto at CAP

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FormaPath made a major unveiling with their exhibit at the 2024 College of American Pathologists Annual Meeting – a desktop configuration of nToto, their automated tissue biopsy grossing system.

NEW YORK, Oct. 31, 2024 /PRNewswire/ — The College of American Pathologists Annual Meeting brings together the brightest minds in the field for CME courses and networking opportunities. Attendees of this year’s meeting in Las Vegas got to be the first to see FormaPath’s latest development – a desktop configuration of its nToto small biopsy grossing system.

The desktop nToto allows users to demonstrate reliability and consistency of robotics and computer vision in their lab

FormaPath first revealed its nToto prototype earlier this year. The system combines robotics and computer vision to transfer small GI biopsies from jars to cassettes and generate images and text descriptions which can be used to populate a gross report via Laboratory Information System integration. The prototype is a free standing unit which has the same footprint as a standard grossing station, and a specimen intake system that allows for automated grossing of 24 jars per hour.

Grossing refers to the macroscopic description of tissue specimens, which consists of visually inspecting the specimens, describing and measuring the tissue, inking if needed, and sectioning the tissue to be processed for diagnosis. FormaPath’s vision is to make Hands Free grossing possible through the application of novel technologies.

The desktop configuration of nToto allows users to demonstrate reliability and consistency of robotics and computer vision within their lab environment, while still maintaining flexibility to configure throughput to individual lab specifications.

nToto was developed in collaboration with Mayo Clinic’s Advanced Diagnostics Laboratory program, where it is currently undergoing clinical validation

FormaPath will begin in-lab demonstrations of the desktop nToto this fall, with plans to launch as a commercial system in the summer of 2025.

About FormaPath:

FormaPath is working to revolutionize the cancer staging process through cutting-edge laboratory automation equipment. We are dedicated to improving patient care by streamlining and automating the diagnostic process. Our equipment minimizes human errors, allowing for rapid and accurate sample processing, reducing turnaround times, and increasing efficiency.

With a commitment to research and innovation, we continuously develop state-of-the-art solutions, empowering healthcare professionals to make informed decisions and provide each cancer patient with their best chance at a positive outcome.

To learn more about FormaPath, visit formapath.com.

Contact:
Phil Lonsdale
Chief of Staff, FormaPath
phil@formapath.com

View original content:https://www.prnewswire.com/news-releases/formapath-demonstrate-mini-ntoto-at-cap-302292890.html

SOURCE FormaPath

Staff

Recent Posts

TE Connectivity declares quarterly dividend

GALWAY, Ireland, June 11, 2025 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL) announced today that…

6 hours ago

SRM Equity Partners Acquires RF Technologies, a Leader in Safety and Security Solutions for Healthcare and Senior Living

BROOKFIELD, Wis., June 11, 2025 /PRNewswire/ -- SRM Equity Partners ("SRM"), an operationally focused private…

6 hours ago

New Findings from NSC Grant Recipients Help Tackle America’s Most Common Workplace Injury

MSD Solutions Lab programs unite academic researchers and industry partners to drive innovation WASHINGTON, June…

6 hours ago

Version 3.0 AI Automation Platform Launches at VGM’s Heartland Conference

Darby 3.0 automates patient intake workflows from fax to EMR, helping HME providers scale without…

6 hours ago

AllSci Wins Grant to Expand AI Platform for Pharma and Biotech R&D: Accelerating Hypothesis-Driven Discovery

Empowering researchers at every level to test hypotheses, validate findings, and collaborate to advance science…

6 hours ago

RIVANNA selected for prestigious MedTech Innovator 2025 Accelerator Cohort

— One of 65 startups chosen from nearly 1,500 global applicants — — Selected to…

6 hours ago